Clinical Effectiveness of Tolvaptan in Patients with Acute Decompensated Heart Failure and Renal Failure: Design and Rationale of the AQUAMARINE Study

2013 ◽  
Vol 28 (1) ◽  
pp. 73-77 ◽  
Author(s):  
Yuya Matsue ◽  
Makoto Suzuki ◽  
Wataru Nagahori ◽  
Kazuki Yoshida ◽  
Yuko Onishi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Renal Failure ◽  
Acute Decompensated Heart Failure ◽  
Clinical Effectiveness ◽  
Decompensated Heart Failure

scholarly journals Acute decompensation of chronic heart failure and renal dysfunction. Diagnosis and treatment

2020 ◽  
Vol 35 (2) ◽  
pp. 35-43
Author(s):  
S. L. Glizer ◽  
O. A. Shtegman ◽  
M. M. Petrova
Keyword(s):  
Heart Failure ◽  
Renal Failure ◽  
Chronic Heart Failure ◽  
Kidney Function ◽  
21St Century ◽  
Social Problem ◽  
Acute Decompensated Heart Failure ◽  
Decompensated Heart Failure ◽  
Common Cause ◽  
Acute Decompensation

Chronic heart failure (CHF) is an essential medical, economic, and social problem of the 21st century. Acute decompensated heart failure (ADHF) is a common cause of hospitalization and mortality in patients with CHF. The article presents the analysis of frequency, prognostic signifi cance, and features of renal failure onset in ADHF patients, as well as the effects of various groups of drugs used in the treatment of ADHF on the kidney function. Special aspects of administering these drugs are elucidated in the context of deteriorating kidney function.

Sign in / Sign up

Export Citation Format

Share Document